VITILIGO KASALLIGIDA IMMUNOLOGIK O’ZGARISHLARNING AHAMIYATI
Main Article Content
Abstract
Ushbu maqolada vitiligo kasalligida muhim ahamiyatga ega bo’lgan immunologik jarayonlarning roli to’g’risida bugungi kun ilm-fan erishgan yutuqlarning natijalari qamrab olingan. To’qimada melanosit apoptozi yoki uning faoliyatini susaytiruvchi promotorlar sifatida ishtirok etuvchi hujayra va to’qima gormonlari - sitokinlarni aniqlash ustida olib boriladigan tekshiruvlar o’rganib chiqiladi. Yig’ilgan ma’lumotlar kasallik etiopatogenezini o’rganishda ahamiyatga ega bo’lgan ma’lumotlar uchun asosiy manba bo’lib xizmat qiladi.
Article Details
References
Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. // Lancet 2015;386:74-84. DOI 10.1016/S0140-6736(14)60763-7
Frisoli ML, Essien K, Harris JE. Vitiligo: Mechanisms of Pathogenesis and Treatment. Annu Rev Immunol 2020;38:621-48. DOI 10.1146/annurev-immunol-100919-023531
Picardo M, Dell’Anna ML, Ezzedine K, Hamzavi I, Harris JE, Parsad D, et al.. Vitiligo. Nat Rev Dis Primers 2015;1:15011. 10.1038/nrdp.2015.11
Boniface K, Seneschal J, Picardo M, Taïeb A. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy. // Clin Rev Allergy Immunol
;54:52-67. DOI 10.1007/s12016-017-8622-7
Van Geel N, Mollet I, Brochez L, Dutré M, De Schepper S, Verhaeghe E, et al.. New Insights in Segmental Vitiligo: Case Report and Review of Theories. // Br J Dermatol 2012;166:240–6. DOI 10.1111/j.1365-2133.2011.10650.x
Boniface K, Seneschal J. Vitiligo as a Skin Memory Disease: The Need for Early Intervention With Immunomodulating Agents and a Maintenance Therapy to Target Resident Memory T Cells. // Exp Dermatol 2019;28:656–61. DOI 10.1111/exd.13879